USSTOCK.TODAY
Market Closed
Log in Sign up

Moderna Announces Cancer Vaccine Clinical Results and Stock Surges

The Motley Fool +1 · ·by G4L

MRNA Moderna Inc
$206.80 -3.93%
View chart & analysis →
  1. 1Moderna announced Phase 3 clinical trial results for its Intismeran cancer vaccine on August 19.
  2. 2Moderna's stock price has risen more than 600% since January, drawing market attention.
  3. 3Moderna's market capitalization reached approximately $90 billion, a significant increase compared to its market capitalization of less than $12 billion in early 2026.

So what's the key point?

Moderna released results from its cancer vaccine trials. The stock price rose by over 600%, leading to a large increase in the company's value.

Source The Motley Fool +1 · View original ↗

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →